PANTHER: IPD Meta-Analysis of Monotherapy with Clopidogrel/Ticagrelor vs. ASA for CAD Secondary Prevention CADACSMeta-analysisMACEASAClopidogrelTicagrelor Jul 21 Written By Jonathan Afilalo Gragnano F, Cao D, Pirondini L, Franzone A, Kim H-S, Scheidt M von, Pettersen A-ÅR, Zhao Q, Woodward M, Chiarito M, McFadden EP, Park KW, Kastrati A, Seljeflot I, Zhu Y, Windecker S, Kang J, Schunkert H, Arnesen H, Bhatt DL, Steg PG, Calabrò P, Pocock S, Mehran R, Valgimigli M, Collaboration P. P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events. J Am Coll Cardiol. 2023;82:89–105. CADACSMeta-analysisASAClopidogrelTicagrelorMACEJACC2023 Jonathan Afilalo
PANTHER: IPD Meta-Analysis of Monotherapy with Clopidogrel/Ticagrelor vs. ASA for CAD Secondary Prevention CADACSMeta-analysisMACEASAClopidogrelTicagrelor Jul 21 Written By Jonathan Afilalo Gragnano F, Cao D, Pirondini L, Franzone A, Kim H-S, Scheidt M von, Pettersen A-ÅR, Zhao Q, Woodward M, Chiarito M, McFadden EP, Park KW, Kastrati A, Seljeflot I, Zhu Y, Windecker S, Kang J, Schunkert H, Arnesen H, Bhatt DL, Steg PG, Calabrò P, Pocock S, Mehran R, Valgimigli M, Collaboration P. P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events. J Am Coll Cardiol. 2023;82:89–105. CADACSMeta-analysisASAClopidogrelTicagrelorMACEJACC2023 Jonathan Afilalo